2022-12-012023-11-302023-11-30false11655509BLOOD & BONES DISTRIBUTION LTD2024-08-2146900iso4217:GBPxbrli:pure116555092022-12-01116555092023-11-30116555092022-12-012023-11-30116555092021-12-01116555092022-11-30116555092021-12-012022-11-3011655509bus:SmallEntities2022-12-012023-11-3011655509bus:AuditExempt-NoAccountantsReport2022-12-012023-11-3011655509bus:FullAccounts2022-12-012023-11-3011655509bus:PrivateLimitedCompanyLtd2022-12-012023-11-3011655509core:WithinOneYear2023-11-3011655509core:AfterOneYear2023-11-3011655509core:WithinOneYear2022-11-3011655509core:AfterOneYear2022-11-3011655509core:ShareCapital2023-11-3011655509core:SharePremium2023-11-3011655509core:RevaluationReserve2023-11-3011655509core:OtherReservesSubtotal2023-11-3011655509core:RetainedEarningsAccumulatedLosses2023-11-3011655509core:ShareCapital2022-11-3011655509core:SharePremium2022-11-3011655509core:RevaluationReserve2022-11-3011655509core:OtherReservesSubtotal2022-11-3011655509core:RetainedEarningsAccumulatedLosses2022-11-3011655509core:LandBuildings2023-11-3011655509core:PlantMachinery2023-11-3011655509core:Vehicles2023-11-3011655509core:FurnitureFittings2023-11-3011655509core:OfficeEquipment2023-11-3011655509core:NetGoodwill2023-11-3011655509core:IntangibleAssetsOtherThanGoodwill2023-11-3011655509core:ListedExchangeTraded2023-11-3011655509core:UnlistedNon-exchangeTraded2023-11-3011655509core:LandBuildings2022-11-3011655509core:PlantMachinery2022-11-3011655509core:Vehicles2022-11-3011655509core:FurnitureFittings2022-11-3011655509core:OfficeEquipment2022-11-3011655509core:NetGoodwill2022-11-3011655509core:IntangibleAssetsOtherThanGoodwill2022-11-3011655509core:ListedExchangeTraded2022-11-3011655509core:UnlistedNon-exchangeTraded2022-11-3011655509core:LandBuildings2022-12-012023-11-3011655509core:PlantMachinery2022-12-012023-11-3011655509core:Vehicles2022-12-012023-11-3011655509core:FurnitureFittings2022-12-012023-11-3011655509core:OfficeEquipment2022-12-012023-11-3011655509core:NetGoodwill2022-12-012023-11-3011655509core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3011655509core:ListedExchangeTraded2022-12-012023-11-3011655509core:UnlistedNon-exchangeTraded2022-12-012023-11-3011655509core:MoreThanFiveYears2022-12-012023-11-3011655509core:Non-currentFinancialInstruments2023-11-3011655509core:Non-currentFinancialInstruments2022-11-3011655509dpl:CostSales2022-12-012023-11-3011655509dpl:DistributionCosts2022-12-012023-11-3011655509core:LandBuildings2022-12-012023-11-3011655509core:PlantMachinery2022-12-012023-11-3011655509core:Vehicles2022-12-012023-11-3011655509core:FurnitureFittings2022-12-012023-11-3011655509core:OfficeEquipment2022-12-012023-11-3011655509dpl:AdministrativeExpenses2022-12-012023-11-3011655509core:NetGoodwill2022-12-012023-11-3011655509core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3011655509dpl:GroupUndertakings2022-12-012023-11-3011655509dpl:ParticipatingInterests2022-12-012023-11-3011655509dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3011655509core:ListedExchangeTraded2022-12-012023-11-3011655509dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3011655509core:UnlistedNon-exchangeTraded2022-12-012023-11-3011655509dpl:CostSales2021-12-012022-11-3011655509dpl:DistributionCosts2021-12-012022-11-3011655509core:LandBuildings2021-12-012022-11-3011655509core:PlantMachinery2021-12-012022-11-3011655509core:Vehicles2021-12-012022-11-3011655509core:FurnitureFittings2021-12-012022-11-3011655509core:OfficeEquipment2021-12-012022-11-3011655509dpl:AdministrativeExpenses2021-12-012022-11-3011655509core:NetGoodwill2021-12-012022-11-3011655509core:IntangibleAssetsOtherThanGoodwill2021-12-012022-11-3011655509dpl:GroupUndertakings2021-12-012022-11-3011655509dpl:ParticipatingInterests2021-12-012022-11-3011655509dpl:GroupUndertakingscore:ListedExchangeTraded2021-12-012022-11-3011655509core:ListedExchangeTraded2021-12-012022-11-3011655509dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-12-012022-11-3011655509core:UnlistedNon-exchangeTraded2021-12-012022-11-3011655509core:NetGoodwill2023-11-3011655509core:IntangibleAssetsOtherThanGoodwill2023-11-3011655509core:LandBuildings2023-11-3011655509core:PlantMachinery2023-11-3011655509core:Vehicles2023-11-3011655509core:FurnitureFittings2023-11-3011655509core:OfficeEquipment2023-11-3011655509core:AfterOneYear2023-11-3011655509core:WithinOneYear2023-11-3011655509core:ListedExchangeTraded2023-11-3011655509core:UnlistedNon-exchangeTraded2023-11-3011655509core:ShareCapital2023-11-3011655509core:SharePremium2023-11-3011655509core:RevaluationReserve2023-11-3011655509core:OtherReservesSubtotal2023-11-3011655509core:RetainedEarningsAccumulatedLosses2023-11-3011655509core:NetGoodwill2022-11-3011655509core:IntangibleAssetsOtherThanGoodwill2022-11-3011655509core:LandBuildings2022-11-3011655509core:PlantMachinery2022-11-3011655509core:Vehicles2022-11-3011655509core:FurnitureFittings2022-11-3011655509core:OfficeEquipment2022-11-3011655509core:AfterOneYear2022-11-3011655509core:WithinOneYear2022-11-3011655509core:ListedExchangeTraded2022-11-3011655509core:UnlistedNon-exchangeTraded2022-11-3011655509core:ShareCapital2022-11-3011655509core:SharePremium2022-11-3011655509core:RevaluationReserve2022-11-3011655509core:OtherReservesSubtotal2022-11-3011655509core:RetainedEarningsAccumulatedLosses2022-11-3011655509core:NetGoodwill2021-12-0111655509core:IntangibleAssetsOtherThanGoodwill2021-12-0111655509core:LandBuildings2021-12-0111655509core:PlantMachinery2021-12-0111655509core:Vehicles2021-12-0111655509core:FurnitureFittings2021-12-0111655509core:OfficeEquipment2021-12-0111655509core:AfterOneYear2021-12-0111655509core:WithinOneYear2021-12-0111655509core:ListedExchangeTraded2021-12-0111655509core:UnlistedNon-exchangeTraded2021-12-0111655509core:ShareCapital2021-12-0111655509core:SharePremium2021-12-0111655509core:RevaluationReserve2021-12-0111655509core:OtherReservesSubtotal2021-12-0111655509core:RetainedEarningsAccumulatedLosses2021-12-0111655509core:AfterOneYear2022-12-012023-11-3011655509core:WithinOneYear2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:CostValuation2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3011655509core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3011655509core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3011655509core:Non-currentFinancialInstrumentscore:CostValuation2022-11-3011655509core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-3011655509core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-3011655509bus:Director12022-12-012023-11-30

BLOOD & BONES DISTRIBUTION LTD

Registered Number
11655509
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2023

BLOOD & BONES DISTRIBUTION LTD
Company Information
for the year from 1 December 2022 to 30 November 2023

Director

Herbert Herris Wright

Registered Address

Chy-An-Bryn
St. Levan
Penzance
TR19 6LN

Registered Number

11655509 (England and Wales)
BLOOD & BONES DISTRIBUTION LTD
Balance Sheet as at
30 November 2023

Notes

2023

2022

£

£

£

£

Creditors amounts falling due within one year3(2,864)(2,265)
Net current assets (liabilities)(2,864)(2,265)
Total assets less current liabilities(2,864)(2,265)
Creditors amounts falling due after one year4(3,000)(3,000)
Net assets(5,864)(5,265)
Capital and reserves
Called up share capital11
Profit and loss account(5,865)(5,266)
Shareholders' funds(5,864)(5,265)
The financial statements were approved and authorised for issue by the Director on 21 August 2024, and are signed on its behalf by:
Herbert Herris Wright
Director
Registered Company No. 11655509
BLOOD & BONES DISTRIBUTION LTD
Notes to the Financial Statements
for the year ended 30 November 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20232022
Average number of employees during the year11
3.Creditors: amounts due within one year

2023

2022

££
Bank borrowings and overdrafts-1
Taxation and social security159245
Other creditors2,0551,440
Accrued liabilities and deferred income650579
Total2,8642,265
4.Creditors: amounts due after one year

2023

2022

££
Other creditors3,0003,000
Total3,0003,000